SECURED CONVERTIBLE PROMISSORY NOTE
(Additional Note #3)
DATE: May 27, 2026
BORROWERS: NKGen Biotech, Inc. and NKGen Operating Biotech, Inc., 3001 Daimler St., Santa Ana, CA 92705
LENDER: AlpineBrook Capital GP I Limited
PRINCIPAL: US$2,420,000
FOR VALUE RECEIVED, each undersigned, NKGen Biotech, Inc. (“NKGen Bio”) and NKGen Operating Biotech, Inc. (each, a “Borrower”) promises to pay to the order of AlpineBrook Capital GP I Limited (“Lender”) (i) in lawful money of the United States of America or, (ii) at the sole and absolute discretion of the Lender, in the form of newly issued shares of common stock of NKGen Bio, par value $0.0001 per share (the “Common Stock”), with applicable registration rights (the “Alternative Equity Repayment”), the principal amount of Two Million Four Hundred Twenty Thousand Dollars (US$2,420,000) or so much as may be outstanding, together with accrued interest and any other amounts
…